Danaher Basic EPS 2010-2024 | DHR
Danaher annual/quarterly basic eps history and growth rate from 2010 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
- Danaher basic eps for the quarter ending December 31, 2024 was $1.50, a 3.45% increase year-over-year.
- Danaher basic eps for the twelve months ending December 31, 2024 was $5.33, a 17.24% decline year-over-year.
- Danaher annual basic eps for 2024 was $0.005B, a 17.24% decline from 2023.
- Danaher annual basic eps for 2023 was $0.006B, a 34.29% decline from 2022.
- Danaher annual basic eps for 2022 was $0.01B, a 11.74% increase from 2021.
| Danaher Annual Basic EPS | |
|---|---|
| 2024 | $5.33 |
| 2023 | $6.44 |
| 2022 | $9.80 |
| 2021 | $8.77 |
| 2020 | $4.97 |
| 2019 | $4.11 |
| 2018 | $3.78 |
| 2017 | $3.58 |
| 2016 | $3.69 |
| 2015 | $4.81 |
| 2014 | $3.70 |
| 2013 | $3.87 |
| 2012 | $3.45 |
| 2011 | $3.21 |
| 2010 | $2.74 |
| 2009 | $1.80 |
| Danaher Quarterly Basic EPS | |
|---|---|
| 2024-12-31 | $1.50 |
| 2024-09-30 | $1.13 |
| 2024-06-30 | $1.23 |
| 2024-03-31 | $1.47 |
| 2023-12-31 | $1.45 |
| 2023-09-30 | $1.53 |
| 2023-06-30 | $1.50 |
| 2023-03-31 | $1.96 |
| 2022-12-31 | $3.04 |
| 2022-09-30 | $2.13 |
| 2022-06-30 | $2.28 |
| 2022-03-31 | $2.35 |
| 2021-12-31 | $2.44 |
| 2021-09-30 | $1.56 |
| 2021-06-30 | $2.44 |
| 2021-03-31 | $2.33 |
| 2020-12-31 | $1.69 |
| 2020-09-30 | $1.18 |
| 2020-06-30 | $1.27 |
| 2020-03-31 | $0.83 |
| 2019-12-31 | $1.76 |
| 2019-09-30 | $0.90 |
| 2019-06-30 | $0.99 |
| 2019-03-31 | $0.46 |
| 2018-12-31 | $1.06 |
| 2018-09-30 | $0.95 |
| 2018-06-30 | $0.96 |
| 2018-03-31 | $0.81 |
| 2017-12-31 | $1.23 |
| 2017-09-30 | $0.82 |
| 2017-06-30 | $0.80 |
| 2017-03-31 | $0.73 |
| 2016-12-31 | $1.07 |
| 2016-09-30 | $0.57 |
| 2016-06-30 | $0.95 |
| 2016-03-31 | $1.10 |
| 2015-12-31 | $0.98 |
| 2015-09-30 | $2.04 |
| 2015-06-30 | $0.98 |
| 2015-03-31 | $0.81 |
| 2014-12-31 | $0.94 |
| 2014-09-30 | $0.97 |
| 2014-06-30 | $0.96 |
| 2014-03-31 | $0.83 |
| 2013-12-31 | $1.13 |
| 2013-09-30 | $0.86 |
| 2013-06-30 | $0.89 |
| 2013-03-31 | $1.00 |
| 2012-12-31 | $0.91 |
| 2012-09-30 | $0.79 |
| 2012-06-30 | $0.86 |
| 2012-03-31 | $0.89 |
| 2011-12-31 | $0.83 |
| 2011-09-30 | $0.76 |
| 2011-06-30 | $0.97 |
| 2011-03-31 | $0.65 |
| 2010-12-31 | $0.72 |
| 2010-09-30 | $0.99 |
| 2010-06-30 | $0.57 |
| 2010-03-31 | $0.46 |
| 2009-12-31 | $0.42 |
| 2009-09-30 | $0.55 |
| 2009-06-30 | $0.46 |
| 2009-03-31 | $0.37 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $160.880B | $23.875B |
| Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $91.772B | 12.00 |
| Cencora (COR) | United States | $49.134B | 18.48 |
| Natera (NTRA) | United States | $23.357B | 0.00 |
| DiDi Global (DIDIY) | China | $22.601B | 0.00 |
| ICON (ICLR) | Ireland | $16.423B | 14.63 |
| Revvity (RVTY) | United States | $15.350B | 25.74 |
| Avantor (AVTR) | United States | $15.164B | 22.74 |
| BioMerieux (BMXMF) | France | $14.363B | 0.00 |
| Viatris (VTRS) | United States | $13.464B | 4.15 |
| CochLear (CHEOY) | Australia | $13.043B | 0.00 |
| Solventum (SOLV) | United States | $12.794B | 0.00 |
| Doximity (DOCS) | United States | $11.033B | 64.94 |
| Medpace Holdings (MEDP) | United States | $10.852B | 30.57 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.405B | 0.00 |
| HealthEquity (HQY) | United States | $9.569B | 48.01 |
| Charles River Laboratories (CRL) | United States | $8.425B | 16.28 |
| Sonic Healthcare (SKHHY) | Australia | $8.349B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $6.136B | 31.28 |
| Bausch + Lomb (BLCO) | Canada | $6.114B | 28.44 |
| BrightSpring Health Services (BTSG) | United States | $4.109B | 87.41 |
| Organon (OGN) | United States | $4.007B | 4.04 |
| Sotera Health (SHC) | United States | $3.883B | 20.77 |
| Surgery Partners (SGRY) | United States | $3.240B | 36.94 |
| Concentras Parent (CON) | United States | $2.968B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.950B | 0.00 |
| PACS (PACS) | United States | $2.214B | 0.00 |
| Premier (PINC) | United States | $2.178B | 11.33 |
| Ardent Health Partners (ARDT) | United States | $2.141B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.056B | 0.00 |
| Progyny (PGNY) | United States | $1.973B | 39.95 |
| GoodRx Holdings (GDRX) | United States | $1.818B | 47.70 |
| Teladoc Health (TDOC) | United States | $1.749B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| Agilon Health (AGL) | United States | $1.376B | 0.00 |
| CareDx (CDNA) | United States | $1.250B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.201B | 11.75 |
| AMN Healthcare Services Inc (AMN) | United States | $1.048B | 7.09 |
| Embecta (EMBC) | United States | $1.042B | 7.29 |
| Establishment Labs Holdings (ESTA) | $0.897B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.639B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.515B | 0.00 |
| SBC Medicals (SBC) | United States | $0.505B | 0.00 |
| DocGo (DCGO) | United States | $0.499B | 18.81 |
| Sonida Senior Living (SNDA) | United States | $0.440B | 0.00 |
| Enhabit (EHAB) | United States | $0.422B | 36.52 |
| QDM (QDMI) | Hong Kong, SAR China | $0.412B | 0.00 |
| MultiPlan (MPLN) | United States | $0.295B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.295B | 0.00 |
| Nutex Health (NUTX) | United States | $0.259B | 0.00 |
| LifeMD (LFMD) | United States | $0.241B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.219B | 0.00 |
| Beauty Health (SKIN) | United States | $0.207B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.185B | 0.00 |
| Biodesix (BDSX) | United States | $0.150B | 0.00 |
| So-Young (SY) | China | $0.108B | 18.32 |
| Oncology Institute (TOI) | United States | $0.076B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.073B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.60 |
| ModivCare (MODV) | United States | $0.057B | 3.10 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| OncoCyte (OCX) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.024B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| KindlyMD (KDLY) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |